Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.206
+0.008 (4.10%)
At close: Feb 21, 2025, 4:00 PM
0.202
-0.004 (-2.04%)
After-hours: Feb 21, 2025, 6:03 PM EST
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $13.46 million as of February 21, 2025. Its market cap has decreased by -94.80% in one year.
Market Cap
13.46M
Enterprise Value
-2.84M
1-Year Change
-94.80%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $13.46M, a decrease of -94.15%. That is a compound annual growth rate of -44.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 13.46M | -0.34% |
Dec 31, 2024 | 13.51M | -95.09% |
Dec 29, 2023 | 275.43M | 175.60% |
Dec 30, 2022 | 99.94M | 76.26% |
Dec 31, 2021 | 56.70M | -61.52% |
Dec 31, 2020 | 147.37M | -35.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 780.72B |
UnitedHealth Group | 470.30B |
Johnson & Johnson | 380.14B |
Novo Nordisk | 370.06B |
AbbVie | 348.39B |
Abbott Laboratories | 229.17B |
AstraZeneca | 228.16B |
Intuitive Surgical | 217.02B |